Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic

Priyanka Anand1, Sebastian Schneeweiss1,2, Arash Mostaghimi2,3

  • 1Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Pediatric Dermatology
|November 20, 2022
PubMed